Tiotropium for Smoking Asthmatics Study

• Status: Withdrawn
• Trial end date: 2014-01-01
• Target enrollment: 0
• Participant gender: All

Summary

The study's research questions concern the appropriateness of use of tiotropium for patients with asthma who are current smokers. It is suggested that patients with asthma who smoke, may in fact share similarities with patients with chronic obstructive pulmonary disease (COPD). Because of this, the study will determine whether this sub-group of patients would in fact benefit from therapy currently approved and marketed for COPD patients.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Alberta
• Treatments: Tiotropium Bromide

Criteria

Inclusion Criteria:

• Male or female patient with a working diagnosis of asthma by clinical presentation or by spirometry testing results.

• Currently prescribed inhaled corticosteroids (ICS) for the treatment of asthma, and may or may not be prescribed additional therapies for asthma.

• Is a current smoker with a minimum of a five year history of smoking.

• Provides written informed consent.

Exclusion Criteria:

• Has a diagnosis of COPD.

• Is currently enrolled in another clinical trial.

• Has any condition which, may decrease the chance of obtaining satisfactory data to achieve the objectives of the study.

• Is unable to provide written informed consent.